感染者|JCO：这种常用药或能帮肝炎患者远离肝癌！( 二 ) 组胺|Journal|研究|患者|常用药

此外，当前肝炎病毒感染者已经有老龄化趋势，往往合并多种慢性疾病，需要长期服用阿司匹林、他汀类药物，而这些药物也可能有一定的防癌作用。将来还得靠前瞻性研究，专门分析H1抗组胺药到底有多大能耐才行。
参考文献：
1.Shen Y C, Hsu H C, Lin T M, et al. H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection[J]. Journal of Clinical Oncology, 2022.
2.Feng Y M, Feng C W, Lu C L, et al. Cyproheptadine significantly improves the overall and progression-free survival of sorafenib-treated advanced HCC patients[J]. Japanese Journal of Clinical Oncology, 2015, 45(4): 336-342.
3.Hsieh M C, Lee W H, Wu A T H, et al. Cyproheptadine use in hepatocellular carcinoma[J]. American Journal of Cancer Research, 2017, 7(3): 584.
4.Liang Y C, Chang C C, Sheu M T, et al. The antihistamine deptropine induces hepatoma cell death through blocking autophagosome-lysosome fusion[J]. Cancers, 2020, 12(6): 1610.
5.He S, Lin B, Chu V, et al. Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection[J]. Science Translational Medicine, 2015, 7(282): 282ra49.
6.Li H, Xiao Y, Yao J, et al. The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1[J]. Cancer Cell, 2022, 40(1): 36-52.E9.
本文作者丨谭硕